Science & Enterprise subscription

Follow us on Twitter

  • Many thanks @SciSeeker https://t.co/uQy4yl5pQb
    about 16 hours ago
  • New post on Science and Enterprise: Taking a Break https://t.co/QgH851GMZX #Science #Business
    about 4 days ago
  • Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000,… https://t.co/cGSC6j1Xl8
    about 4 days ago
  • New post on Science and Enterprise: Infographic – U.S. Venture Funds Near 20-Year Highs https://t.co/mIkraoGRAH #Science #Business
    about 4 days ago
  • A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially c… https://t.co/NHSLm9YBBG
    about 5 days ago

Please share Science & Enterprise

Trial to Test App Alerting for Dementia-Linked Drugs

Phone and keyboard

A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer’s disease will soon be tested in a clinical trial. . . . → Read More: Trial to Test App Alerting for Dementia-Linked Drugs

Chip Device Tests for Cancer Drug Efficacy, Toxicity

A configurable chip device simulating several human organs is shown in lab tests to simultaneously test cancer drugs for both their efficacy and toxicity. . . . → Read More: Chip Device Tests for Cancer Drug Efficacy, Toxicity

Engineered Antibody Delays Type 1 Diabetes Onset

TrialNet participants

Results from a clinical trial show a synthetic antibody delayed for about 2 years the start of type 1 diabetes symptoms among people at high risk of the disease. . . . → Read More: Engineered Antibody Delays Type 1 Diabetes Onset

Small Business Grant Funds Diabetes Rescue Device

Diabetes blood glucose test

A device to rescue people with diabetes experiencing low blood sugar is being developed by an Indiana company and Purdue University pharmacy lab. . . . → Read More: Small Business Grant Funds Diabetes Rescue Device

Biotech, NIH Partner on Opioid Alternative Discovery

Pills and dollar bill

A company creating human tissue samples from stem cells is partnering with National Center for Advancing Translational Sciences, or NCATS, to help find new alternatives to opioid drugs. . . . → Read More: Biotech, NIH Partner on Opioid Alternative Discovery

Tissue Chip Experiments Set for Space Station

Astronaut with tissue chip

A collection of 4 new tissue chip experiments are among the payloads to be sent next week to the International Space Station or ISS. . . . → Read More: Tissue Chip Experiments Set for Space Station

NIH Launches Universal Flu Vaccine Trial

3-D print of influenza virus

A clinical trial testing a vaccine designed to prevent infections from many influenza strains is underway at National Institutes of Health. . . . → Read More: NIH Launches Universal Flu Vaccine Trial

Respiratory Vaccine Maker Raises $3.4M in Seed Funds

lung illustration

A company developing vaccines that protect against respiratory diseases in vulnerable populations is raising new seed funds to advance its lead product into clinical trials. . . . → Read More: Respiratory Vaccine Maker Raises $3.4M in Seed Funds

NIH Funds Natural Hearing Restoration Technology

Florian Solzbacher

An international group of universities and companies is designing a next-generation device to restore more natural hearing to people suffering from hearing loss. . . . → Read More: NIH Funds Natural Hearing Restoration Technology

NIH Funding Nanodrugs to Prevent Opioid Addiction

Head in hands

A drug that invokes the immune system to block addictive effects of opioid pain drugs and heroin is in early development at Washington University in St. Louis. . . . → Read More: NIH Funding Nanodrugs to Prevent Opioid Addiction